Find MS events and support groups near you! Get started >>

Medications for Fabry Disease

Drugs associated with Fabry Disease

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Fabry Disease: Storage disease due to deficiency of ceramide trihexosidase.

Drug name	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Fabrazyme	Rx	B	N	Add review	Add
Generic name: agalsidase beta systemic Drug class: lysosomal enzymes For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information

agalsidase beta	Rx	B	N	Add review	Add
Generic name: agalsidase beta systemic Brand name: Fabrazyme Drug class: lysosomal enzymes For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph

Showing all

Off Label	This medication may not be approved by the FDA for the treatment of this condition.

Prescription Only / Over the Counter
Rx	Prescription Only
OTC	Over the Counter
Rx/OTC	Prescription or Over the Counter

Pregnancy
A	Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C	Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N	FDA has not classified the drug.

Controlled Substances Act Schedule
N	The drug is not subject to the Controlled Substances Act.
1	The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2	The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3	The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4	The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5	The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.

Alcohol
X	Interacts with Alcohol.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z